 Long-term therapy HIV-associated Kaposi sarcoma recombinant interferon young male patients HIV-associated Kaposi sarcoma KS recombinant interferon alpha period years IFN dose IU day first months treatment alternate days Additional treatment radiotherapy laser therapy cases isolated skin nodules months initiation therapy patient complete remission tumours tumour progression patient treatment patient tumour months rIFN therapy months free KS condition third patient stabilized first months therapy months slow progression fourth fifth patients months histological diagnosis KS initiation treatment therapy life-threatening opportunistic infections side-effects severe changes haematological parameters therapy